dalteparin has been researched along with Hemophilia A in 7 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Hemophilia A: The classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage.
| Excerpt | Relevance | Reference |
|---|---|---|
| "There were 23 patients with hemophilia, 18 (78%) with hemophilia A and 5 (22%) with hemophilia B, who underwent high-risk surgeries (39% THR and 61% TKA)." | 2.82 | Thromboprophylaxis and Incidence of Venous Thromboembolism in Patients With Hemophilia A or B Who Underwent High-Risk Orthopedic Surgeries. ( Akbar, SA; Doll, DC; Dong, X; Freter, CE; Holm, L; Hopkins, T; Hossain, AM; Kale, G; Kim, D; Naidzionak, U; Raza, S, 2016) |
| " An antithrombotic prophylaxis at low dosage was immediately started, then increased at prophylactic dosage." | 1.56 | How haemophilia A impacts severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) treatment: a case report. ( Campello, E; Pasca, S; Simioni, P; Spiezia, L; Vettor, R; Zanon, E, 2020) |
| "Venous thrombosis is a very rare occurrence in patients with haemophilia A." | 1.31 | Thrombosis in a duplicated superficial femoral vein in a patient with haemophilia A. ( Allan, PL; Dennis, R; Ludlam, CA; Manson, LM; Stewart, AJ, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Zanon, E | 1 |
| Pasca, S | 1 |
| Campello, E | 1 |
| Spiezia, L | 1 |
| Vettor, R | 1 |
| Simioni, P | 1 |
| Raza, S | 1 |
| Kale, G | 1 |
| Kim, D | 1 |
| Akbar, SA | 1 |
| Holm, L | 1 |
| Naidzionak, U | 1 |
| Hossain, AM | 1 |
| Dong, X | 1 |
| Doll, DC | 1 |
| Freter, CE | 1 |
| Hopkins, T | 1 |
| Marwick, C | 1 |
| De Giorgi, A | 1 |
| Giannarelli, C | 1 |
| De Negri, F | 1 |
| Carmassi, F | 1 |
| Galán, AM | 1 |
| Tonda, R | 1 |
| Altisent, C | 1 |
| Maragall, S | 1 |
| Ordinas, A | 1 |
| Escolar, G | 1 |
| Wu, IQ | 1 |
| Tan, CW | 1 |
| Wong, WH | 1 |
| Ng, HJ | 1 |
| Stewart, AJ | 1 |
| Manson, LM | 1 |
| Dennis, R | 1 |
| Allan, PL | 1 |
| Ludlam, CA | 1 |
1 trial available for dalteparin and Hemophilia A
| Article | Year |
|---|---|
Thromboprophylaxis and Incidence of Venous Thromboembolism in Patients With Hemophilia A or B Who Underwent High-Risk Orthopedic Surgeries.
Topics: Adult; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Compression Bandages; Enoxaparin; Fa | 2016 |
6 other studies available for dalteparin and Hemophilia A
| Article | Year |
|---|---|
How haemophilia A impacts severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) treatment: a case report.
Topics: Aged; Betacoronavirus; Blood Coagulation; Coronavirus Infections; COVID-19; Enoxaparin; Female; Fibr | 2020 |
Better control coming for clotting and bleeding.
Topics: Anticoagulants; Blood Coagulation Factors; Enoxaparin; Genetic Therapy; Hemophilia A; Hemostasis; Hu | 1999 |
Thromboprophylaxis with reviparin in a patient with acquired hemophilia.
Topics: Aged; Anemia, Hemolytic, Autoimmune; Autoantibodies; Carcinoma, Renal Cell; Factor VIII; Hemophilia | 2005 |
Recombinant factor VIIa (Novoseven) restores deficient coagulation: experience from an ex vivo model.
Topics: Adult; Anticoagulants; Blood Coagulation; Blood Platelets; Coagulants; Dalteparin; Factor VII; Facto | 2001 |
Utility of global hemostatic assays in the management of anticoagulation in a haemophilia patient.
Topics: Anticoagulants; Coronary Angiography; Factor VIII; Hemophilia A; Hemorrhage; Humans; International N | 2018 |
Thrombosis in a duplicated superficial femoral vein in a patient with haemophilia A.
Topics: Adult; Factor VIII; Femoral Vein; Fibrinolytic Agents; Hemophilia A; Heparin, Low-Molecular-Weight; | 2000 |